Pitfalls in Urine Cytology: A Case of Fumarate Hydratase-Deficient Renal Cell Carcinoma Initially Diagnosed as High-Grade Urothelial Carcinoma

被引:0
|
作者
Cheng, Kai [1 ]
Zhang, Xuelian [2 ]
Zhou, Xiaodie [1 ]
Wang, Xiaotong [1 ]
Bao, Wei [1 ]
Rao, Qiu [1 ,2 ]
机构
[1] Nanjing Univ, Med Sch, Affiliated Hosp, Dept Pathol,Jinling Hosp, Nanjing, Jiangsu, Peoples R China
[2] Nanjing King Med Med Lab Co Ltd, Dept Pathol, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
cytomorphologic features; FH-deficient RCC; liquid-based; Papanicolaou staining; urinary cytology; KIDNEY;
D O I
10.1002/dc.25409
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare, aggressive, hereditary subtype of renal cancer that requires careful diagnostic considerations. We report a case of a 33-year-old Asian woman who presented with a 20-day history of hematuria. Imaging studies revealed a solid tumor in the lower pole of the right kidney with lymph node metastases. Urinary cytology revealed benign squamous cells, inflammatory cells, and atypical epithelial cells, suggestive of high-grade urothelial carcinoma. Following a right nephrectomy, the tumor displayed papillary structures composed of cells exhibiting atypical, elongated nuclei with eosinophilic nucleoli and peripheral halos. Immunohistochemical staining demonstrated negative FH expression. Genetic analysis identified a somatic missense mutation in the FH gene, confirming the diagnosis of FH-deficient RCC. This case highlights the importance of integrating cytological, histological, and genetic analyses for accurate diagnosis of FH-deficient RCC.
引用
收藏
页码:E11 / E16
页数:6
相关论文
共 29 条
  • [1] Response to systemic therapy in fumarate hydratase-deficient renal cell carcinoma
    Carril-Ajuria, Lucia
    Colomba, Emeline
    Cerbone, Luigi
    Romero-Ferreiro, Carmen
    Crouzet, Laurence
    Laguerre, Brigitte
    Thibault, Constance
    Vicier, Cecile
    de Velasco, Guillermo
    Flechon, Aude
    Saldana, Carolina
    Benusiglio, Patrick R.
    Bressac-de Paillerets, Brigitte
    Guillaud-Bataille, Marine
    Gaignard, Pauline
    Scoazec, Jean-Yves
    Richard, Stephane
    Caron, Olivier
    Escudier, Bernard
    Albiges, Laurence
    EUROPEAN JOURNAL OF CANCER, 2021, 151 : 106 - 114
  • [2] Fumarate Hydratase-Deficient Renal Cell Carcinoma With Predominant Tubulocystic Features Mimics Tubulocystic Renal Cell Carcinoma
    Yang, Xiaoqun
    Liu, Yang
    Wang, Huafeng
    Xu, Yunze
    Zhang, Huizhi
    Zhao, Ming
    Luo, Xiaoqing
    Jin, Hongtao
    Xiong, Ji
    Tao, Lili
    Xu, Jiankun
    Zhou, Luting
    Li, Xiangyun
    Xu, Haimin
    Dong, Lei
    Wang, Chaofu
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (12) : 1358 - 1364
  • [3] Multidetector CT Characteristics of Fumarate Hydratase-Deficient Renal Cell Carcinoma and Papillary Type II Renal Cell Carcinoma
    Yang, Ling
    Li, Xue-Ming
    Hu, Ya-Jun
    Zhang, Meng-Ni
    Yao, Jin
    Song, Bin
    KOREAN JOURNAL OF RADIOLOGY, 2021, 22 (12) : 1996 - 2005
  • [4] Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Gleeson, Jack P.
    Nikolovski, Ines
    Dinatale, Renzo
    Zucker, Mark
    Knezevic, Andrea
    Patil, Sujata
    Ged, Yasser
    Kotecha, Ritesh R.
    Shapnik, Natalie
    Murray, Samuel
    Russo, Paul
    Coleman, Jonathan
    Lee, Chung Han
    Stadler, Zsofia K.
    Hakimi, A. Ari
    Feldman, Darren R.
    Motzer, Robert J.
    Reznik, Ed
    Voss, Martin H.
    Chen, Ying-Bei
    Carlo, Maria, I
    CLINICAL CANCER RESEARCH, 2021, 27 (10) : 2910 - 2919
  • [5] Comparative analyses of tumour immune microenvironment between collecting duct carcinoma and fumarate hydratase-deficient renal cell carcinoma
    Kiyozawa, Daisuke
    Kohashi, Kenichi
    Takamatsu, Dai
    Umekita, Shinya
    Eto, Masatoshi
    Kinjo, Mitsuru
    Nishiyama, Kenichi
    Taguchi, Kenichi
    Oshiro, Yumi
    Kuboyama, Yusuke
    Oda, Yoshinao
    JOURNAL OF CLINICAL PATHOLOGY, 2024, 77 (02) : 105 - 110
  • [6] Case #7. Cytology of high-grade urothelial carcinoma
    Comperat, Eva
    ANNALES DE PATHOLOGIE, 2025, 45 (02) : 144 - 146
  • [7] Approach for reclassification of collecting duct carcinoma and comparative histopathological analysis with SMARCB1/INI1-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma
    Kiyozawa, Daisuke
    Kohashi, Kenichi
    Takamatsu, Dai
    Iwasaki, Takeshi
    Shibata, Daiki
    Tomonaga, Takumi
    Tateishi, Yuki
    Eto, Masatoshi
    Kinjo, Mitsuru
    Nishiyama, Kenichi
    Taguchi, Kenichi
    Oshiro, Yumi
    Kuboyama, Yusuke
    Furuya, Mitsuko
    Oda, Yoshinao
    HUMAN PATHOLOGY, 2022, 124 : 36 - 44
  • [8] AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Zheng, Linmao
    Zhang, Xingming
    Pan, Xiuyi
    Huang, Zhuo
    Zhang, Mengxin
    Xian, Jie
    Wei, Yuyan
    Nie, Ling
    Zhang, Mengni
    Gong, Jing
    Chen, Xueqin
    Zhou, Qiao
    Zeng, Hao
    Chen, Ni
    MODERN PATHOLOGY, 2023, 36 (11)
  • [9] Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors
    Hamza, Ameer
    Sirohi, Deepika
    Smith, Steven C.
    Amin, Mahul B.
    ADVANCES IN ANATOMIC PATHOLOGY, 2021, 28 (06) : 396 - 407
  • [10] Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 cases
    Pivovarcikova, Kristyna
    Martinek, Petr
    Grossmann, Petr
    Trpkov, Kiril
    Alaghehbandan, Reza
    Magi-Galluzzi, Cristina
    Pane Foix, Maria
    Condom Mundo, Enric
    Berney, Daniel
    Gill, Anthony
    Rychlyh, Boris
    Michalova, Kvetoslava
    Rogala, Joanna
    Pitra, Tomas
    Micsik, Tamas
    Polivka, Jiri
    Hora, Milan
    Isikci, Ozlem Tanas
    Skalova, Sarka
    Mareckova, Jana
    Michal, Michal
    Hes, Ondrej
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2019, 39 : 63 - 68